Skip to main content

Day: August 22, 2023

Sentient Brands Holdings Inc. Signs Letter of Intent with Major International Food and Beverage Products Manufacturer

NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) — Sentient Brands Holdings Inc. (OTC Markets: SNBH) (“Sentient Brands” and the “Company”) (www.sentientbrands.com), a next-level product and brand development company with a strategic mission to develop and market high value products and services, today announced that it has entered into a Letter of Intent with American Industrial Group, Inc. (“AIG”) in connection with the Company’s potential acquisition of AIG’s portfolio of alcohol and non-alcoholic beverage, confectionery, and baking goods businesses. As part of its M&A strategy, Sentient Brands has been actively seeking attractive potential acquisition targets with the goal of strengthening the Company’s business model and augmenting its revenue, intellectual property, and global footprint. Sentient Brands is a holding company with...

Continue reading

Global Carbon Credit Trading Platform Market Size to Reach USD 1,019.3 Million in 2032 | Emergen Research

Increasing interest of investors in Environmental, Social, and Governance (ESG) is a key factor driving market revenue growth Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) — The global market for carbon credit trading platforms recorded a size of USD 107.2 million in 2022 and is projected to maintain a steady compound annual growth rate (CAGR) of 25.5% throughout the forecast period, as per the most recent analysis conducted by Emergen Research. The significant surge in technological investments aimed at carbon capture and removal stands out as a primary catalyst propelling the upward trajectory of market revenues. Carbon credits have garnered escalating popularity as both businesses and individuals seek avenues to curtail their contribution to climate change. This inclination has spurred the fossil fuel sector to enhance its operational...

Continue reading

Kaixin Auto Holdings Announces Completion of Morning Star Acquisition and Entry into New Energy Vehicles Manufacturing

BEIJING, Aug. 22, 2023 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced the closing of the acquisition of Morning Star Auto Inc. (“Morning Star”). Following the closing, Morning Star has become a wholly-owned subsidiary of Kaixin, which represents the Company’s official entry into the field of new energy vehicle manufacturing. Mr. Mingjun Lin, chairman and CEO of Kaixin, said: “The Company has gone through a long journey in its transformation into the new energy vehicles business, and the successful completion of the Morning Star acquisition is an important milestone in the successful transformation of Kaixin!” According to the latest statistics, China’s automobile exports during the first half of 2023 increased by 75.7% year-on-year to 2.14 million vehicles,...

Continue reading

GDS Holdings Limited Reports Second Quarter 2023 Results

SHANGHAI, China, Aug. 22, 2023 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China and South East Asia, today announced its unaudited financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial HighlightsNet revenue increased by 7.0% year-over-year (“Y-o-Y”) to RMB2,472.0 million (US$340.9 million) in the second quarter of 2023 (2Q2022: RMB2,310.4 million). Service revenue increased by 7.4% Y-o-Y to RMB2,472.0 million (US$340.9 million) in the second quarter of 2023 (2Q2022: RMB2,302.7 million). Net loss was RMB225.3 million (US$31.1 million) in the second quarter of 2023 (2Q2022: net loss of RMB375.3 million). Adjusted EBITDA (non-GAAP) increased by 16.3% Y-o-Y to...

Continue reading

LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

Significant progress with lead program LAVA-1207 in mCRPC reaching dose level 8 Significant progress with collaborators including selection of lead candidate by Janssen Biotech and IND clearance for SGN-EGFRd2 (LAVA-1223) by Seagen Portfolio reprioritization and extension of cash runway into 2026UTRECHT, The Netherlands and PHILADELPHIA, Aug. 22, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma-delta T cell engagers, today announced recent corporate highlights and financial results for the quarter ended June 30, 2023. “We are focused on driving forward our lead program, LAVA-1207 in patients with mCRPC and are pleased our Gammabody® platform continues to receive the support of investigators and...

Continue reading

Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders

Presentations Highlight New Data on Diagnostic Accuracy and Novel Biomarkers of Disease Severity in Multiple System Atrophy MELBOURNE, Australia and SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that poster presentations from its bioMUSE natural history study of Multiple System Atrophy (MSA) will be delivered at the International Congress of Parkinson’s Disease and Movement Disorders taking place August 27 – 31, 2023 in Copenhagen, Denmark.Title: A multimodal approach for diagnosis of early Multiple System AtrophyPresenter: Daniel O. Claassen, M.D., M.S., Professor of Neurology, Vanderbilt University Medical CenterAbstract...

Continue reading

Form 8.3 – [EMIS Group plc – 21 08 2023] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Verde Appoints Chief Marketing Officer

Newton Nagumo brings over two decades of successful communication and marketing planning expertise to boost Verde’s market strategy SINGAPORE, Aug. 22, 2023 (GLOBE NEWSWIRE) — Verde AgriTech Ltd (TSX: “NPK”) (“Verde” or the “Company”) is pleased to announce the appointment of marketing veteran Newton Nagumo to the position of Chief Marketing Officer (“CMO”). Mr. Nagumo is brand marketing leader with a 20-year track record of driving transformative innovation and guiding high-performing teams to achieve substantial growth for major Brazilian and global corporations. Mr. Nagumo will join Verde’s leadership team to oversee brand and product marketing, creative initiatives, consumer insights, and global communications. As CMO, Mr. Nagumo will collaborate closely with the operations team to bolster sales efforts and will...

Continue reading

Global Immunoassay Market Size to Reach USD 55.85 Billion in 2030 | Emergen Research

Increase in prevalence of chronic and infectious diseases is a key factor driving market revenue growth Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) — The global immunoassay market attained a significant valuation of USD 39.72 Billion in the year 2021. Projections based on the latest analysis by Emergen Research indicate that the market is anticipated to sustain a compound annual growth rate (CAGR) of 3.9% throughout the forecast period. This growth trajectory is attributed to the escalating prevalence of both chronic and infectious ailments, which serves as a substantial impetus for the expansion of market revenue. Remarkably, the International Diabetes Federation (IDF) reported that approximately 537 million individuals across the globe were grappling with diabetes in the year 2021. This statistic is projected to ascend, reaching...

Continue reading

Global Digital Transformation Market Size to Reach USD 2,669.48 Billion in 2030 | Emergen Research

Increasing awareness among organizations to adopt digital technology is a key factor driving digital transformation market revenue growth Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) — The global market for digital transformation attained a significant size of USD 492.43 Billion in the year 2021. Forecasts from the latest analysis by Emergen Research indicate an anticipated compound annual growth rate (CAGR) of 20.8% in revenue over the projected period. This growth trajectory is primarily propelled by the escalating recognition among enterprises regarding the importance of integrating digital technology. Digital transformation refers to the strategic employment of digital technology for the purpose of innovating or adapting current business processes, organizational culture, and customer interactions. This strategic shift is driven...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.